Navigation Links
NxStage Medical to Present at JMP Securities Healthcare Focus Conference
Date:9/30/2008

LAWRENCE, Mass., Sept. 30 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, and Robert S. Brown, Chief Financial Officer, will be presenting at the JMP Securities Healthcare Focus Conference on October 6, 2008 at Le Parker Meridien Hotel in New York.

NxStage's investor presentation is scheduled for Monday, October 6th at 2:30 p.m. ET. To listen to the audio webcast of the presentation during the event, please visit: http://www.nxstage.com and click on 'Investor Information.' A replay will be available for 30 days immediately following the live presentation.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate,"
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NxStage Announces Investor Conference Schedule
2. NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population
3. NxStage Medical to Present at William Blair Growth Stock Conference
4. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
5. NxStage Medical Announces Needle Supply Agreement with DaVita
6. NxStage Medical to Present at the Piper Jaffray Healthcare Conference on November 27, 2007
7. Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical
8. NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd
9. NxStage Medical Provides Update on Medisystems Acquisition
10. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
11. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Protocol Networks brings ... growing team of brand-neutral, independent consultants, Protocol Networks has ... explained that over the years, his company has attracted ... Town of Plainfield, as well as others. With the ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited ... seminar on probiotics in San Diego, CA. , The ... for health care professionals. This year’s pre-conference seminar was held ... health. Dr. Leyer spoke about the emerging topics and science ...
(Date:1/22/2015)... , Nueva Jersey , 22 de enero ... for Biomedical Research abre hoy su llamada a nominaciones ... cuya investigación científica ha hecho, o tiene el potencial ... salud humana. Las nominaciones se aceptarán hasta el 15 ...
(Date:1/22/2015)... N.J. , Jan. 22, 2015  Derma Sciences, ... regeneration company focused on advanced wound care, announces ... placental tissues, have been added to the Premier, ... increases the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® ...
Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... Preclinical-Stage Compounds ... in Merck KGaA Pipeline, ... discovery and development company, announced today that,it will collaborate with ... new applications for drug candidates. KineMed,s,proprietary pathway-based drug discovery and ...
... YORK, August 28 XTL Biopharmaceuticals,Ltd. (NASDAQ: ... company,engaged in the acquisition, development and commercialization of,therapeutics ... pain and hepatitis C, today announced that issuances ... depositary bank,The Bank of New York, will be ...
... ... FY2007 Annual Targets Under Review, BEIJING, Aug. 28 ... CMED ), a leading China-based,medical device company that develops, ... intensity focused ultrasound tumor,therapy system, today announced its unaudited ...
Cached Biology Technology:KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates 2Processing Fees on ADRs to be Waived for two Months 2Processing Fees on ADRs to be Waived for two Months 3China Medical Technologies Reports First Quarter Financial Results 2China Medical Technologies Reports First Quarter Financial Results 3China Medical Technologies Reports First Quarter Financial Results 4China Medical Technologies Reports First Quarter Financial Results 5China Medical Technologies Reports First Quarter Financial Results 6China Medical Technologies Reports First Quarter Financial Results 7China Medical Technologies Reports First Quarter Financial Results 8China Medical Technologies Reports First Quarter Financial Results 9China Medical Technologies Reports First Quarter Financial Results 10China Medical Technologies Reports First Quarter Financial Results 11China Medical Technologies Reports First Quarter Financial Results 12China Medical Technologies Reports First Quarter Financial Results 13China Medical Technologies Reports First Quarter Financial Results 14
(Date:12/22/2014)... SHELTON, Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile commerce ... consultant, Apollo Robbins for the 2015 International CES ... Apollo Robbins will be at the NXT-ID booth ...
(Date:12/19/2014)... 18, 2014  23andMe, Inc., the leading personal genetics company, today ... in genetic ancestry of individuals from across the ... more than four hundred years ago, the United ... peoples from different continents. This study illuminates how American history ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader ... PerformTek biometric technology to industry leaders such as Intel, ... clinically validated, biometric wearable products. These products will be ... Las Vegas . ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... DURHAM, N.H. A team of chemists from ... stable derivative of nonacene, creating a compound that holds ... such as large displays, solar cells and radio frequency ... chemistry and materials science Glen Miller and including two ...
... (Feb. 11, 2010) For years, doctors have warned patients ... by a "superbug" that can mount a more powerful defense ... University biomedical engineers indicates that treating bacteria with levels of ... to a wide range of antibiotics. In the Feb. ...
... at Queen,s University suggest that policy makers examine ... as fossil fuel sources must be rapidly replaced ... renewable energy., Their recommendations could be used to ... a way that will optimize greenhouse gas emission ...
Cached Biology News:UNH chemists create molecule with promising semiconductor properties 2Low levels of antibiotics cause multidrug resistance in 'superbugs' 2Low levels of antibiotics cause multidrug resistance in 'superbugs' 3Queen's researchers propose rethinking renewable energy strategy 2
... The GeneSwitch Cell Lines stably ... pSwitch. Each cell line is functionally ... transfection with the expression control vector ... expression after treatment with mifepristone (Figure ...
... OrientExpress™ System Modules ... and directional cloning into ... expression vectors ... OrientExpress™ Cloning Systems, the ...
... CHEMICON Re-Blot Western Blot Recycling Kit ... from Western blots that have been ... or other isotopes. It is not ... DAB, 4-chloronapthol, etc.), as it is ...
Applications: Western blotting ...
Biology Products: